Inotiv Logo INVESTORS Investor Information Corporate Profile Inotiv, Inc., provides drug discovery and development services and analytical instruments that help pharmaceutical, biotechnology, leading academic institutions and government organizations in their drug development and research efforts. Our mission is to provide drug developers with superior scientific research and innovative analytical instrumentation, which saves time, saves money, and saves lives, to bring revolutionary new drugs to market quickly and safely. Our strategy is to provide services that will generate high-quality and timely data in support of new drug approval or use expansion. To learn more about our portfolio of services, click here. Click here for our latest investor presentation. Investor News Click here to view Form 8937, Report of Organizational Actions Affecting Basis of Securities, for the Merger with Envigo RMS Holdings Corp on November 5, 2021. Click here for the webcast of Inotiv’s presentation at the Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at 12:20pm GMT. Click here to view the presentation deck. Click here for the recording of the Envigo Acquisition Conference Call held on Tuesday, September 21, 2021, at 10:00am ET. Click here to view the presentation deck. Click here for the recording of our Q3 FY 2021 Financial Results Conference Call held Wednesday, August 11, 2021, at 4:30pm ET. Click here for the recording of our Q2 FY 2021 Financial Results Conference Call held on Wednesday, May 5, 2021, at 4:30pm ET. Click here to listen to the audio recording of the BASi/Inotiv 2021 Annual Meeting of Shareholders held on Thursday, March 18, 2021. Click here to listen to the March 9-10, 2021, webcast of BASi/Inotiv’s presentation at the H.C. Wainwright Global Life Sciences Virtual Conference. Click here to view the presentation deck. Click here for the recording of our Q1 FY 2021 Financial Results Conference Call held on Tuesday, February 9, 2021, at 4:30pm ET. Click here to listen to the September 16, 2020, recording of BASi/Inotiv’s presentation at the H.C. Wainwright 22nd Annual Global Investment Conference. Click here to view the presentation deck. SEC Filings | Section 16 Filings Inotiv, Inc. Releases Earnings for Third Quarter of Fiscal 2021 August 11, 2021 Results Market Quotes by TradingView Investor Relations Beth A. Taylor, Chief Financial Officer Inotiv, Inc. 765.497.8381 Email Kalle Ahl, CFA The Equity Group 212.836.9614 Email Devin Sullivan The Equity Group 212.836.9608 Email Get the Insights You Deserve Answering the right questions on time and with high-quality data is the key to achieving your objectives. Expect more. GET IN TOUCH Inotiv Logo 2701 Kent Avenue West Lafayette, IN 47906 USA 800.845.4246 765.463.4527 Copyright © 2021 Inotiv. All Rights Reserved. Privacy Terms Of Use Contact